Logo image of OABI

OMNIAB INC (OABI) Stock Fundamental Analysis

USA - NASDAQ:OABI - US68218J1034 - Common Stock

1.52 USD
-0.04 (-2.56%)
Last: 11/17/2025, 8:03:32 PM
1.4 USD
-0.12 (-7.89%)
Pre-Market: 11/18/2025, 5:26:57 AM
Fundamental Rating

3

OABI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. While OABI has a great health rating, there are worries on its profitability. While showing a medium growth rate, OABI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OABI has reported negative net income.
In the past year OABI has reported a negative cash flow from operations.
In the past 5 years OABI always reported negative net income.
In multiple years OABI reported negative operating cash flow during the last 5 years.
OABI Yearly Net Income VS EBIT VS OCF VS FCFOABI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

OABI has a worse Return On Assets (-21.28%) than 67.24% of its industry peers.
OABI has a Return On Equity (-24.05%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -21.28%
ROE -24.05%
ROIC N/A
ROA(3y)-12.64%
ROA(5y)-10.55%
ROE(3y)-14.75%
ROE(5y)-12.65%
ROIC(3y)N/A
ROIC(5y)N/A
OABI Yearly ROA, ROE, ROICOABI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

1.3 Margins

OABI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OABI Yearly Profit, Operating, Gross MarginsOABI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

More info and screens

7

2. Health

2.1 Basic Checks

OABI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OABI has more shares outstanding
There is no outstanding debt for OABI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OABI Yearly Shares OutstandingOABI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OABI Yearly Total Debt VS Total AssetsOABI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

OABI has an Altman-Z score of 2.05. This is not the best score and indicates that OABI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.05, OABI is in line with its industry, outperforming 56.90% of the companies in the same industry.
There is no outstanding debt for OABI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.05
ROIC/WACCN/A
WACC10.24%
OABI Yearly LT Debt VS Equity VS FCFOABI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

OABI has a Current Ratio of 3.69. This indicates that OABI is financially healthy and has no problem in meeting its short term obligations.
OABI has a Current ratio of 3.69. This is in the better half of the industry: OABI outperforms 62.07% of its industry peers.
OABI has a Quick Ratio of 3.67. This indicates that OABI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.67, OABI is in the better half of the industry, outperforming 67.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.69
Quick Ratio 3.67
OABI Yearly Current Assets VS Current LiabilitesOABI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.45% over the past year.
OABI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.75%.
The Revenue has been growing slightly by 7.57% on average over the past years.
EPS 1Y (TTM)6.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)-22.75%
Revenue growth 3Y-8.76%
Revenue growth 5Y7.57%
Sales Q2Q%-46.33%

3.2 Future

Based on estimates for the next years, OABI will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.06% on average per year.
Based on estimates for the next years, OABI will show a very strong growth in Revenue. The Revenue will grow by 26.49% on average per year.
EPS Next Y1.4%
EPS Next 2Y13.53%
EPS Next 3Y12.9%
EPS Next 5Y13.06%
Revenue Next Year-15.88%
Revenue Next 2Y11.92%
Revenue Next 3Y23%
Revenue Next 5Y26.49%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OABI Yearly Revenue VS EstimatesOABI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
OABI Yearly EPS VS EstimatesOABI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OABI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OABI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OABI Price Earnings VS Forward Price EarningsOABI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OABI Per share dataOABI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

OABI's earnings are expected to grow with 12.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.53%
EPS Next 3Y12.9%

More info and screens

0

5. Dividend

5.1 Amount

OABI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OMNIAB INC

NASDAQ:OABI (11/17/2025, 8:03:32 PM)

Premarket: 1.4 -0.12 (-7.89%)

1.52

-0.04 (-2.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)03-16 2026-03-16/amc
Inst Owners45.12%
Inst Owner ChangeN/A
Ins Owners6.58%
Ins Owner Change8.59%
Market Cap186.50M
Revenue(TTM)26.39M
Net Income(TTM)-63.00M
Analysts84.62
Price Target8.67 (470.39%)
Short Float %6.5%
Short Ratio9.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.36%
Min EPS beat(2)-1.63%
Max EPS beat(2)4.35%
EPS beat(4)1
Avg EPS beat(4)-3.98%
Min EPS beat(4)-14.18%
Max EPS beat(4)4.35%
EPS beat(8)3
Avg EPS beat(8)-1.06%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.82%
Min Revenue beat(2)-28.38%
Max Revenue beat(2)-9.26%
Revenue beat(4)1
Avg Revenue beat(4)-21.1%
Min Revenue beat(4)-51.31%
Max Revenue beat(4)4.57%
Revenue beat(8)2
Avg Revenue beat(8)-22.01%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.92%
PT rev (3m)7.94%
EPS NQ rev (1m)2.97%
EPS NQ rev (3m)0.09%
EPS NY rev (1m)1.07%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.1
P/FCF N/A
P/OCF N/A
P/B 0.71
P/tB 4.05
EV/EBITDA N/A
EPS(TTM)-0.58
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS0.19
BVpS2.14
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.28%
ROE -24.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-12.64%
ROA(5y)-10.55%
ROE(3y)-14.75%
ROE(5y)-12.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.55%
Cap/Sales 2.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.69
Quick Ratio 3.67
Altman-Z 2.05
F-Score4
WACC10.24%
ROIC/WACCN/A
Cap/Depr(3y)36.85%
Cap/Depr(5y)29.78%
Cap/Sales(3y)13.66%
Cap/Sales(5y)12.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y1.4%
EPS Next 2Y13.53%
EPS Next 3Y12.9%
EPS Next 5Y13.06%
Revenue 1Y (TTM)-22.75%
Revenue growth 3Y-8.76%
Revenue growth 5Y7.57%
Sales Q2Q%-46.33%
Revenue Next Year-15.88%
Revenue Next 2Y11.92%
Revenue Next 3Y23%
Revenue Next 5Y26.49%
EBIT growth 1Y7.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.29%
EBIT Next 3Y13.66%
EBIT Next 5YN/A
FCF growth 1Y-782.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-608.74%
OCF growth 3YN/A
OCF growth 5YN/A

OMNIAB INC / OABI FAQ

What is the ChartMill fundamental rating of OMNIAB INC (OABI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to OABI.


What is the valuation status for OABI stock?

ChartMill assigns a valuation rating of 0 / 10 to OMNIAB INC (OABI). This can be considered as Overvalued.


How profitable is OMNIAB INC (OABI) stock?

OMNIAB INC (OABI) has a profitability rating of 1 / 10.


What is the financial health of OMNIAB INC (OABI) stock?

The financial health rating of OMNIAB INC (OABI) is 7 / 10.